Symptomatic, pharmacological treatment of myasthenia gravis.

Authors

DOI:

https://doi.org/10.17161/rrnmf.v4i3.19548

Keywords:

myasthenia gravis, symptomatic treatment, pyridostigmine, amifampridine, adrenergic agonist

Metrics

File downloads
755
Aug 31 '23Sep 01 '23Sep 04 '23Sep 07 '23Sep 10 '23Sep 13 '23Sep 16 '23Sep 19 '23Sep 22 '23Sep 25 '236.0
|

Downloads

Downloads

Published

2023-08-29

Issue

Vol. 4 No. 3 (2023): Proceedings of the MGFA International Conference

Section

MGFA International Conference Proceedings

License

Copyright (c) 2023 Linda Remijn-Nelissen, Wisse R. Bakker, Teun van Gelder, Martijn R. Tannemaat, Jan J.G.M. Verschuuren

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

Remijn-Nelissen, L., Bakker, W., van Gelder, T., Tannemaat, M., & Verschuuren, J. (2023). Symptomatic, pharmacological treatment of myasthenia gravis. RRNMF Neuromuscular Journal, 4(3). https://doi.org/10.17161/rrnmf.v4i3.19548